Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2005

01.02.2005

Multicenter Analysis of Clinicopathologic Features of Intraductal Papillary Mucinous Tumor of the Pancreas: Is It Possible to Predict the Malignancy Before Surgery?

verfasst von: Jin-Young Jang, MD, Sun-Whe Kim, MD, FACS, Young Joon Ahn, MD, Yoo-Seok Yoon, MD, Min Gew Choi, MD, Kuhn Uk Lee, MD, Joon Koo Han, MD, Woo Ho Kim, MD, Young Joo Lee, MD, Song Chul Kim, MD, Duck Jong Han, MD, Yong Il Kim, MD, Seong Ho Choi, MD, Baik Hwan Cho, MD, Hee Chul Yu, MD, Dong Sup Yoon, MD, Woo Jung Lee, MD, Kyung Bum Lee, MD, Young Chul Kim, MD, Kwang Soo Lee, MD, Myung-Wook Kim, MD, Hong Jin Kim, MD, Hyun Jong Kim, MD, Yong-Hyun Park, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite recently increasing numbers of reports on intraductal papillary mucinous tumors (IPMTs), difficulties still remain in terms of diagnosis, treatment, and prognosis. The purpose of this multicenter study was to evaluate the clinicopathologic features of IPMT in Korea and to suggest predictive criteria for malignancy in IPMT.

Methods

We retrospectively reviewed the clinicopathologic data of 208 patients who underwent operations for IPMT between 1993 and 2002 at 28 institutes in Korea.

Results

Of the 208 patients (mean age, 61 years), 147 were men and 61 were women. A total of 124 patients underwent pancreatoduodenectomy, 42 underwent distal pancreatectomy, 17 underwent total pancreatectomy, and 25 underwent limited pancreatic resection. There were 128 benign cases (adenoma, n = 62; borderline, n = 66) and 80 malignant cases (noninvasive, n = 29; invasive, n = 51). A significant difference in 5-year survival was observed between the benign and malignant groups (92.6% vs. 65.3%; P = .006). Of the six factors (age, location, duct dilatation, mural nodule, main duct type, and tumor size) that showed statistical differences by univariate analysis between the benign and malignant groups, three were significant by multivariate analysis—namely, mural nodule (P = .009), tumor size (P = .023), and a dilated duct size (P = .010).

Conclusions

A significant proportion of IPMTs are malignant, although the overall prognosis of IPMT is superior to that of ordinary pancreatic cancer. Radical surgery is recommended for IPMT with the predictors of malignancy: mural nodule, tumor size (⩾30 mm), and dilated duct size (⩾12 mm).
Literatur
1.
Zurück zum Zitat Ohhashi, K, Murakami, F, Murayama, M, et al. 1982Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater (in Japanese)Prog Dig Endosc2034851 Ohhashi, K, Murakami, F, Murayama, M,  et al. 1982Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater (in Japanese)Prog Dig Endosc2034851
2.
Zurück zum Zitat Sugiyama, M, Atomi, Y 1998Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategiesAnn Surg22868591PubMed Sugiyama, M, Atomi, Y 1998Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategiesAnn Surg22868591PubMed
3.
Zurück zum Zitat Yamaguchi, K, Tanaka, M 1991Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papillaAm J Gastroenterol868359PubMed Yamaguchi, K, Tanaka, M 1991Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papillaAm J Gastroenterol868359PubMed
4.
Zurück zum Zitat Obara, T, Maguchi, H, Saitoh, Y, et al. 1991Mucin-producing tumor of the pancreas: a unique clinical entityAm J Gastroenterol86161925PubMed Obara, T, Maguchi, H, Saitoh, Y,  et al. 1991Mucin-producing tumor of the pancreas: a unique clinical entityAm J Gastroenterol86161925PubMed
5.
Zurück zum Zitat Sugiyama, M, Izumisato, Y, Abe, N, Masaki, T, Mori, T, Atomi, Y 2003Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreasBr J Surg9012449PubMed Sugiyama, M, Izumisato, Y, Abe, N, Masaki, T, Mori, T, Atomi, Y 2003Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreasBr J Surg9012449PubMed
6.
Zurück zum Zitat McDonald, JM, Williard, W, Mais, D, Beitler, A 2000The incidence of intraductal papillary mucinous tumors of the pancreasCurr Surg576104PubMed McDonald, JM, Williard, W, Mais, D, Beitler, A 2000The incidence of intraductal papillary mucinous tumors of the pancreasCurr Surg576104PubMed
7.
Zurück zum Zitat Nagai, E, Ueki, T, Chijiiwa, K, Tanaka, M, Tsuneyoshi, M 1995Intraductal papillary mucinous neoplasms of the pancreas associated with so-called “mucinous ductal ectasia.” Histochemical and immunohistochemical analysis of 29 casesAm J Surg Pathol1957689CrossRefPubMed Nagai, E, Ueki, T, Chijiiwa, K, Tanaka, M, Tsuneyoshi, M 1995Intraductal papillary mucinous neoplasms of the pancreas associated with so-called “mucinous ductal ectasia.” Histochemical and immunohistochemical analysis of 29 casesAm J Surg Pathol1957689CrossRefPubMed
8.
Zurück zum Zitat Azar, C, Stadt, J, Rickaert, F, et al. 1996Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patientsGut3945764PubMed Azar, C, Stadt, J, Rickaert, F,  et al. 1996Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patientsGut3945764PubMed
9.
Zurück zum Zitat Traverso, LW, Peralta, EA, Ryan, JA,Jr, Kozarek, RA 1998Intraductal neoplasms of the pancreasAm J Surg17542632PubMed Traverso, LW, Peralta, EA, Ryan, JA,Jr, Kozarek, RA 1998Intraductal neoplasms of the pancreasAm J Surg17542632PubMed
10.
Zurück zum Zitat Cuillerier, E, Cellier, C, Palazzo, L, et al. 2000Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreasAm J Gastroenterol954415PubMed Cuillerier, E, Cellier, C, Palazzo, L,  et al. 2000Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreasAm J Gastroenterol954415PubMed
11.
Zurück zum Zitat Hara, T, Yamaguchi, T, Ishihara, T, et al. 2002Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonographyGastroenterology1223443PubMed Hara, T, Yamaguchi, T, Ishihara, T,  et al. 2002Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonographyGastroenterology1223443PubMed
12.
Zurück zum Zitat Wakabayashi, T, Kawaura, Y, Morimoto, H, et al. 2001Clinical management of intraductal papillary mucinous tumors of the pancreas based on imaging findingsPancreas223707PubMed Wakabayashi, T, Kawaura, Y, Morimoto, H,  et al. 2001Clinical management of intraductal papillary mucinous tumors of the pancreas based on imaging findingsPancreas223707PubMed
13.
Zurück zum Zitat Z’graggen, K, Rivera, JA, Compton, CC, et al. 1997Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreasAnn Surg2264918CrossRefPubMed Z’graggen, K, Rivera, JA, Compton, CC,  et al. 1997Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreasAnn Surg2264918CrossRefPubMed
14.
Zurück zum Zitat Kondo, H, Sugano, K, Fukayama, N, et al. 1997Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreasCancer799005PubMed Kondo, H, Sugano, K, Fukayama, N,  et al. 1997Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreasCancer799005PubMed
15.
Zurück zum Zitat Kaino, M, Kondoh, S, Okita, S, et al. 1999Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumorsPancreas182949PubMed Kaino, M, Kondoh, S, Okita, S,  et al. 1999Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumorsPancreas182949PubMed
16.
Zurück zum Zitat Biankin, AV, Biankin, SA, Kench, JG, et al. 2002Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinomaGut508618CrossRefPubMed Biankin, AV, Biankin, SA, Kench, JG,  et al. 2002Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinomaGut508618CrossRefPubMed
17.
Zurück zum Zitat Inoue, H, Tsuchida, A, Kawasaki, Y, Fujimoto, Y, Yamasaki, S, Kajiyama, G 2001Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activityCancer913541CrossRefPubMed Inoue, H, Tsuchida, A, Kawasaki, Y, Fujimoto, Y, Yamasaki, S, Kajiyama, G 2001Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activityCancer913541CrossRefPubMed
18.
Zurück zum Zitat Luttges, J, Feyerabend, B, Buchelt, T, Pacena, M, Kloppel, G 2002The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreasAm J Surg Pathol2646671PubMed Luttges, J, Feyerabend, B, Buchelt, T, Pacena, M, Kloppel, G 2002The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreasAm J Surg Pathol2646671PubMed
19.
Zurück zum Zitat Bernard, P, Scoazec, JY, Joubert, M, et al. 2002Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 casesArch Surg13712748PubMed Bernard, P, Scoazec, JY, Joubert, M,  et al. 2002Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 casesArch Surg13712748PubMed
20.
Zurück zum Zitat Yamaguchi, K, Ogawa, Y, Chijiiwa, K, Tanaka, M 1996Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperativelyAm J Surg17142731PubMed Yamaguchi, K, Ogawa, Y, Chijiiwa, K, Tanaka, M 1996Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperativelyAm J Surg17142731PubMed
21.
Zurück zum Zitat Furukawa, T, Takahashi, T, Kobari, M, Matsuno, S 1992The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mappingCancer70150513PubMed Furukawa, T, Takahashi, T, Kobari, M, Matsuno, S 1992The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mappingCancer70150513PubMed
22.
Zurück zum Zitat Itoh, S, Ishiguchi, T, Ishigaki, T, Sakuma, S, Maruyama, K, Senda, K 1992Mucin-producing pancreatic tumor: CT findings and histopathologic correlationRadiology183816PubMed Itoh, S, Ishiguchi, T, Ishigaki, T, Sakuma, S, Maruyama, K, Senda, K 1992Mucin-producing pancreatic tumor: CT findings and histopathologic correlationRadiology183816PubMed
23.
Zurück zum Zitat Obara, T, Maguchi, H, Saitoh, Y, et al. 1993Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changesAm J Gastroenterol885649PubMed Obara, T, Maguchi, H, Saitoh, Y,  et al. 1993Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changesAm J Gastroenterol885649PubMed
24.
Zurück zum Zitat Kobari, M, Egawa, S, Shibuya, K, et al. 1999Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical managementArch Surg13411316PubMed Kobari, M, Egawa, S, Shibuya, K,  et al. 1999Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical managementArch Surg13411316PubMed
25.
Zurück zum Zitat Kamisawa, T, Fujiwara, T, Tu, Y, et al. 2002Long-term follow-up of intraductal papillary adenoma of the pancreasJ Gastroenterol3786873PubMed Kamisawa, T, Fujiwara, T, Tu, Y,  et al. 2002Long-term follow-up of intraductal papillary adenoma of the pancreasJ Gastroenterol3786873PubMed
26.
Zurück zum Zitat Kanazumi, N, Nakao, A, Kaneko, T, et al. 2001Surgical treatment of intraductal papillary-mucinous tumors of the pancreasHepatogastroenterology4896771PubMed Kanazumi, N, Nakao, A, Kaneko, T,  et al. 2001Surgical treatment of intraductal papillary-mucinous tumors of the pancreasHepatogastroenterology4896771PubMed
27.
Zurück zum Zitat Chari, ST, Yadav, D, Smyrk, TC, et al. 2002Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreasGastroenterology12315007PubMed Chari, ST, Yadav, D, Smyrk, TC,  et al. 2002Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreasGastroenterology12315007PubMed
28.
Zurück zum Zitat Sugiyama, M, Atomi, Y 1999Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreasAm J Gastroenterol944703PubMed Sugiyama, M, Atomi, Y 1999Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreasAm J Gastroenterol944703PubMed
29.
Zurück zum Zitat Brat, DJ, Lillemoe, KD, Yeo, CJ, Warfield, PB, Hruban, RH 1998Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreasAm J Surg Pathol221639PubMed Brat, DJ, Lillemoe, KD, Yeo, CJ, Warfield, PB, Hruban, RH 1998Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreasAm J Surg Pathol221639PubMed
30.
Zurück zum Zitat Yamaguchi, K, Ohuchida, J, Ohtsuka, T, Nakano, K, Tanaka, M 2002Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreasPancreatology248490PubMed Yamaguchi, K, Ohuchida, J, Ohtsuka, T, Nakano, K, Tanaka, M 2002Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreasPancreatology248490PubMed
Metadaten
Titel
Multicenter Analysis of Clinicopathologic Features of Intraductal Papillary Mucinous Tumor of the Pancreas: Is It Possible to Predict the Malignancy Before Surgery?
verfasst von
Jin-Young Jang, MD
Sun-Whe Kim, MD, FACS
Young Joon Ahn, MD
Yoo-Seok Yoon, MD
Min Gew Choi, MD
Kuhn Uk Lee, MD
Joon Koo Han, MD
Woo Ho Kim, MD
Young Joo Lee, MD
Song Chul Kim, MD
Duck Jong Han, MD
Yong Il Kim, MD
Seong Ho Choi, MD
Baik Hwan Cho, MD
Hee Chul Yu, MD
Dong Sup Yoon, MD
Woo Jung Lee, MD
Kyung Bum Lee, MD
Young Chul Kim, MD
Kwang Soo Lee, MD
Myung-Wook Kim, MD
Hong Jin Kim, MD
Hyun Jong Kim, MD
Yong-Hyun Park, MD
Publikationsdatum
01.02.2005
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2005
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2005.02.030

Weitere Artikel der Ausgabe 2/2005

Annals of Surgical Oncology 2/2005 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.